Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-17
    E.g., 2018-10-17

Archive Search

1 results
12:00 AM, Aug 19, 2013  |  BioCentury | Emerging Company Profile

SynapDx: Autism early warning

controls. The company is testing an improved version of the gene expression signature, termed the SDX-002
data from about half of the patients will be used to refine the analysis of SDX-002
cohort of about 360 patients will be used to assess the sensitivity and concordance between SDX-002